×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BNTC – benitec biopharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BNTC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
11:20 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $18.00 to $20.00. They now have a "market outperform" rating on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $18.00 to $20.00. They now have a "market outperform" rating on the stock.
3/25
08:00 am
bntc
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
Medium
Report
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
3/24
08:09 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
High
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/19
07:00 am
bntc
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Low
Report
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
3/10
07:15 am
bntc
Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Medium
Report
Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
2/26
07:00 am
bntc
Benitec Biopharma to Participate in Upcoming Conferences in March
Medium
Report
Benitec Biopharma to Participate in Upcoming Conferences in March
2/21
08:13 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
2/20
07:17 pm
bntc
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable [Yahoo! Finance]
Medium
Report
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/2
04:37 pm
bntc
Form 4 Benitec Biopharma Inc. For: Mar 31 Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Medium
Report
Form 4 Benitec Biopharma Inc. For: Mar 31 Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
3/28
05:13 pm
bntc
Form 8-K Benitec Biopharma Inc. For: Mar 26
Medium
Report
Form 8-K Benitec Biopharma Inc. For: Mar 26
3/28
04:52 pm
bntc
Form 4 Benitec Biopharma Inc. For: Mar 26 Filed by: Averill Madison Master Fund, Ltd.
Medium
Report
Form 4 Benitec Biopharma Inc. For: Mar 26 Filed by: Averill Madison Master Fund, Ltd.
3/28
04:51 pm
bntc
Form SCHEDULE 13D/A Benitec Biopharma Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Medium
Report
Form SCHEDULE 13D/A Benitec Biopharma Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
3/27
05:10 pm
bntc
Form 8-K Benitec Biopharma Inc. For: Mar 26
Low
Report
Form 8-K Benitec Biopharma Inc. For: Mar 26
3/26
10:53 am
bntc
Form 424B5 Benitec Biopharma Inc.
Low
Report
Form 424B5 Benitec Biopharma Inc.
3/26
08:13 am
bntc
Form 8-K Benitec Biopharma Inc. For: Mar 25
Medium
Report
Form 8-K Benitec Biopharma Inc. For: Mar 25
3/20
05:25 pm
bntc
Form 8-K Benitec Biopharma Inc. For: Mar 20
Medium
Report
Form 8-K Benitec Biopharma Inc. For: Mar 20
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/20
BENITEC BIOPHAR/S (NASDAQ: BNTC) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $14.00 price target on the stock.
109.0%
4/14 Form 25-NSE Benitec Biopharma LTD/AD Filed by: The Nasdaq Stock Market LLC 33.9%
7/31 ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report 28.8%
3/26 Benitec Announces Results of Scheme Meeting 11.9%
4/17 Form EFFECT Benitec Biopharma LTD/AD 6.6%
10/31 Appendix 4C: Quarterly Cash Flow Report 5.2%
9/16 Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program 1.6%
4/27 Form 3 Benitec Biopharma Inc. For: Apr 15 Filed by: SOON-SHIONG PATRICK 1.3%
4/14 Form 25-NSE Benitec Biopharma LTD/AD Filed by: The Nasdaq Stock Market LLC 33.9%
7/31 ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report 28.8%
3/26 Benitec Announces Results of Scheme Meeting 11.9%
4/17 Form EFFECT Benitec Biopharma LTD/AD 6.6%
10/31 Appendix 4C: Quarterly Cash Flow Report 5.2%
9/16 Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program 1.6%
4/27 Form 3 Benitec Biopharma Inc. For: Apr 15 Filed by: SOON-SHIONG PATRICK 1.3%
TOP News Decliners
6/6
Update on Oculopharyngeal Muscular Dystrophy Program
-34.2%
9/19 Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference -14.0%
11/27 ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States -10.2%
4/3 Form 6-K Benitec Biopharma LTD/AD For: Apr 03 -7.5%
1/31 Appendix 4C: Quarterly Cash Flow Report -6.7%
4/27 Form 3 Benitec Biopharma Inc. For: Apr 15 Filed by: Boston Megan -1.6%
9/19 Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference -14.0%
11/27 ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States -10.2%
4/3 Form 6-K Benitec Biopharma LTD/AD For: Apr 03 -7.5%
1/31 Appendix 4C: Quarterly Cash Flow Report -6.7%
4/27 Form 3 Benitec Biopharma Inc. For: Apr 15 Filed by: Boston Megan -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: